Literature DB >> 23846209

Growth of type 1 neovascularization following cessation of anti-vascular endothelial growth factor therapy as a possible explanation for treatment resistance.

Vinnie P Shah, K Bailey Freund.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23846209     DOI： 10.1001/jamaophthalmol.2013.2120

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN： 2168-6165            Impact factor:   7.389


× No keyword cloud information.
  2 in total

1.  Revascularization after angiogenesis inhibition favors new sprouting over abandoned vessel reuse.

Authors:  Anthony Mukwaya; Pierfrancesco Mirabelli; Anton Lennikov; Muthukumar Thangavelu; Maria Ntzouni; Lasse Jensen; Beatrice Peebo; Neil Lagali
Journal:  Angiogenesis       Date:  2019-09-04       Impact factor: 9.596

2.  Long-Term Visual Outcomes for a Treat and Extend Anti-Vascular Endothelial Growth Factor Regimen in Eyes with Neovascular Age-Related Macular Degeneration.

Authors:  Sarah Mrejen; Jesse J Jung; Christine Chen; Samir N Patel; Roberto Gallego-Pinazo; Nicolas Yannuzzi; Luna Xu; Marcela Marsiglia; Sucharita Boddu; K Bailey Freund
Journal:  J Clin Med       Date:  2015-07-08       Impact factor: 4.241
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.